ERBB2 and neoplasm: With radioisotope 124I labeling, the covalent nanobody enhanced radionuclide accumulationand showed prolonged residence in HER2-expressing tumors while stillmaintaining fast clearance from circulation in mice, which enabledexceptional contrast for tumor detection and low background activityin other tissues for molecular imaging in mice.